Daily and circadian rhythms of tissue factor pathway inhibitor and factor VII activity

被引:76
|
作者
Pinotti, M
Bertolucci, C
Portaluppi, F
Colognesi, I
Frigato, E
Foà, A
Bernardi, F
机构
[1] Univ Ferrara, Dipartmento Biochim & Biol Mol, I-44100 Ferrara, Italy
[2] Univ Ferrara, Dept Biol, I-44100 Ferrara, Italy
[3] Univ Ferrara, Ctr Neurosci, I-44100 Ferrara, Italy
[4] Univ Ferrara, Dept Med Clin & Sperimentale, I-44100 Ferrara, Italy
关键词
factor VII; TFPI; circadian; feeding schedule; mouse model;
D O I
10.1161/01.ATV.0000153140.13148.e0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective - Diurnal variations in levels of factor VII ( FVII), FVIII, proteins C and S, antithrombin, plasminogen activator inhibitor- 1, prothrombin fragment F1+2, and D-dimers in healthy humans point to the existence of circadian rhythms of coagulation factors. We sought for temporal fluctuations of tissue factor pathway inhibitor ( TFPI) activity in human and mouse plasma. Methods and Results - TFPI activity showed significant daily variations with highest levels in the morning in healthy men ( + 11%) and in mice at the light-to-dark transition ( + 63%), the beginning of the physically active period. Variations in FVII activity paralleled those in TFPI. In mice, the feeding schedule had a strong impact on these rhythms. Although restricted feeding and fasting shifted the peak of TFPI, the FVII peak disappeared. Investigation of temporal fluctuations in constant darkness indicated the existence of daily rhythms for TFPI and of true circadian rhythms for FVII. Conclusions - For the first time, we report, both in humans and mice, temporal variations in TFPI activity. The coherent variations in FVII and TFPI activity could interplay to maintain the coagulation equilibrium. The chronobiological patterns should be considered to analyze activity levels of these factors. Moreover, the mouse model could be exploited to investigate modifiers of coagulation rhythms potentially associated to morning peaks of cardiovascular events.
引用
收藏
页码:646 / 649
页数:4
相关论文
共 50 条
  • [31] Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor
    Godoi, Lara Carvalho
    Gomes, Karina Braga
    Alpoim, Patricia Nessralla
    Carvalho, Maria das Gracas
    Lwaleed, Bashir A.
    Sant'Ana Dusse, Luci Maria
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2012, 34 (01) : 1 - 6
  • [32] Tissue factor pathway inhibitor and tissue factor in HD and CAPD
    Malyszko, J
    Malyszko, JS
    Mysliwiec, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (09) : 2424 - 2426
  • [33] Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor
    Lara Carvalho Godoi
    Karina Braga Gomes
    Patrícia Nessralla Alpoim
    Maria das Graças Carvalho
    Bashir A. Lwaleed
    Luci Maria Sant’Ana Dusse
    Journal of Thrombosis and Thrombolysis, 2012, 34 : 1 - 6
  • [34] Site-directed mutagenesis of tissue factor pathway inhibitor- binding exosite D60A on factor VII results in a new factor VII variant with lower coagulant activity
    Seanoon, Karnsasin
    Kitiyanant, Vorawat
    Payongsri, Panwajee
    Sirachainan, Nongnuch
    Angchaisuksiri, Pantep
    Chuansumrit, Ampaiwan
    Hongeng, Suradej
    Tanratana, Pansakorn
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (01)
  • [35] Enhancement of lipoprotein lipase activity by tissue factor pathway inhibitor
    Mukherjee, M
    Kakkar, VV
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (06) : 1648 - 1651
  • [36] Activated factor XI enhances procoagulant tissue factor activity on endothelial cells by cleaving tissue factor pathway inhibitor
    Puy, C.
    Tucker, E. L.
    Gruber, A.
    McCarty, O. J. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 96 - 96
  • [37] Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor
    Puy, Cristina
    Tucker, Erik I.
    Matafonov, Anton
    Cheng, Qiufang
    Zientek, Keith D.
    Gailani, Dave
    Gruber, Andras
    McCarty, Owen J. T.
    BLOOD, 2015, 125 (09) : 1488 - 1496
  • [38] ACTIVATED FACTOR XI INCREASES THE PROCOAGULANT ACTIVITY OF THE EXTRINSIC PATHWAY BY INACTIVATING TISSUE FACTOR PATHWAY INHIBITOR
    Puy, C.
    Tucker, E. I.
    Gailani, D.
    Gruber, A.
    McCarty, O. J. T.
    THROMBOSIS RESEARCH, 2014, 133 : S6 - S6
  • [39] Factor Xa cleavage of tissue factor pathway inhibitor is associated with loss of anticoagulant activity
    Salemink, I
    Franssen, J
    Willems, GM
    Hemker, HC
    Li, AG
    Wun, TC
    Lindhout, T
    THROMBOSIS AND HAEMOSTASIS, 1998, 80 (02) : 273 - 280
  • [40] Intra-alveolar tissue factor pathway inhibitor is not sufficient to block tissue factor procoagulant activity
    Bastarache, Julie A.
    Wang, Ling
    Wang, Zhengming
    Albertine, Kurt H.
    Matthay, Michael A.
    Ware, Lorraine B.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 294 (05) : L874 - L881